Fenofibrate Export Market Intelligence: India's 168 Suppliers Shipping to 81 Countries — TransData Nexus 2026

Q: Who are the top fenofibrate exporters from India?

The top fenofibrate exporters from India are: 1. ABBOTT HEALTHCARE PRIVATE LIMITED — $10.6M (14.5% market share); 2. HETERO LABS LIMITED — $8.3M (11.3% market share); 3. CIPLA LIMITED — $7.1M (9.7% market share); 4. SUN PHARMACEUTICAL INDUSTRIES LIMITED — $7.0M (9.6% market share); 5. ATHENA DRUG DELIVERY SOLUTIONS PRIVATE LIMITED — $6.0M (8.2% market share). Together they account for 53.3% of India's total fenofibrate export value.

Q: What is the total export value of fenofibrate from India?

The total export value of fenofibrate from India is $73.4M USD, recorded across 2,794 shipment transactions from 168 active exporters to 81 destination countries. The average shipment value is $26.3K.

Q: Which countries import fenofibrate from India?

India exports fenofibrate to 81 countries worldwide. The top importing countries are: UNITED STATES (43.4% share, $31.8M), BELGIUM (8.7% share, $6.4M), AUSTRALIA (8.2% share, $6.0M), SOUTH KOREA (6.4% share, $4.7M), FRANCE (6.4% share, $4.7M). These five markets account for 73.0% of total export value.

Q: What is the HS code for fenofibrate exports from India?

The primary HS code for fenofibrate exports from India is 30049099. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) for tracking and reporting pharmaceutical trade flows.

Q: What is the average price of fenofibrate exports from India?

The average unit price for fenofibrate exports from India is $8.19 USD per unit, with prices ranging from $0.00 to $749.73 depending on formulation, packaging, and order volume. The total market is valued at $73.4M across 2,794 shipments.

Q: Which ports handle fenofibrate exports from India?

The primary ports for fenofibrate exports from India are NHAVA SHEVA SEA (INNSA1) (12.9% of shipments), SAHAR AIR (10.1% of shipments), SAHAR AIR CARGO ACC (INBOM4) (8.2% of shipments), DELHI AIR CARGO ACC (INDEL4) (8.1% of shipments), JNPT/ NHAVA SHEVA SEA (7.3% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Q: Why is India a leading exporter of fenofibrate?

India is one of the world's leading exporters of fenofibrate due to its large base of 168 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports fenofibrate to 81 countries, demonstrating 42% global market coverage.

Q: What certifications do Indian fenofibrate exporters need?

Indian fenofibrate exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

Q: How many buyers import fenofibrate from India?

There are 368 registered buyers importing fenofibrate from India, spread across 81 countries. The repeat buyer rate is 59.5%, indicating strong long-term trade relationships and consistent product quality.

Q: What is the market share of the top fenofibrate supplier from India?

ABBOTT HEALTHCARE PRIVATE LIMITED is the leading fenofibrate exporter from India with a market share of 14.5% and total export value of $10.6M across 50 shipments. The top 5 suppliers together control 53.3% of total export value.

Suresh Sormare

Fenofibrate

India Pharmaceutical Trade Intelligence

$73.4M168 Suppliers81 CountriesHS 30049099

ExportsIndia → UNITED STATES43.4%India → BELGIUM8.7%

ImportsUNITED STATES → India$13.3K CANADA → India$3.1K

#1 Buyer: YUSEN LOGISTICS

Fenofibrate Export Analysis | India Pharmaceutical Trade Intelligence | TransData Nexus

How India Exports Fenofibrate to the World

Between 2022 and 2026, India exported $73.4M worth of fenofibrate across 2,794 verified shipments to 81 countries — covering 42% of world markets in the Lipid & Metabolism segment. The largest destination is UNITED STATES (43.4%). ABBOTT HEALTHCARE PRIVATE LIMITED leads with a 14.5% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published March 2026·Updated March 2026·

Fenofibrate export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Fenofibrate export data snapshot — $73.4M · 168 exporters · 81 countriesTransData Nexus · Indian Customs Data

Top Fenofibrate Exporters from India

168 active exporters · Ranked by export value

View all 168 →

Top Fenofibrate Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	ABBOTT HEALTHCARE PRIVATE LIMITED	$10.6M	50	5	14.5%
2	HETERO LABS LIMITED

Top Countries Importing Fenofibrate from India

81 destination markets · Ranked by import value

All 81 countries →

Top Countries Importing Fenofibrate from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	UNITED STATES	$31.8M	43.4%
2	BELGIUM	$6.4M	8.7%
3	AUSTRALIA	$6.0M	8.2%
4	SOUTH KOREA	$4.7M	6.4%
5	FRANCE	$4.7M	6.4%
6	HUNGARY	$4.2M	5.7%
7	PHILIPPINES	$3.1M	4.2%
8	NETHERLANDS	$2.0M	2.7%
9	BRAZIL	$1.4M	2.0%
10	SLOVENIA	$1.3M	1.8%

UNITED STATES is India's largest fenofibrate export destination, absorbing 43.4% of total exports worth $31.8M. The top 5 importing countries — UNITED STATES, BELGIUM, AUSTRALIA, SOUTH KOREA, FRANCE — together account for 73.0% of India's total fenofibrate export value. The remaining 76 destination countries collectively receive the other 27.0%, indicating a broadly diversified export footprint across multiple regions.

Who Supplies Fenofibrate to India?

13 origin countries · Total import value: $26.7K

India imports fenofibrate from 13 countries with a combined import value of $26.7K. The largest supplier is UNITED STATES ($13.3K, 7 shipments), followed by CANADA and UNITED KINGDOM. All values are from Indian Customs (DGFT) import records.

Countries Supplying Fenofibrate to India — Ranked by Import Value
#	Origin Country	Import Value (USD)	Shipments	Share
1	UNITED STATES	$13.3K	7	49.7%
2	CANADA	$3.1K	13	11.6%
3	UNITED KINGDOM	$2.1K	6	7.9%
4	IRELAND	$1.6K	3	6.1%
5	BULGARIA	$1.4K	3	5.1%
6	MALTA	$1.2K	2	4.6%
7	CHINA	$966	7	3.6%
8	NETHERLANDS	$950	1	3.6%
9	GERMANY	$776	1	2.9%
10	SPAIN	$612	1	2.3%

Showing top 10 of 13 origin countries

UNITED STATES is the largest supplier of fenofibrate to India, accounting for 49.7% of total import value. The top 5 origin countries — UNITED STATES, CANADA, UNITED KINGDOM, IRELAND, BULGARIA — together supply 80.3% of India's fenofibrate imports. Click any country to see detailed supplier and buyer data for that import corridor.

Fenofibrate — Export Intelligence Video

Visual overview of India's fenofibrate import and export market — top suppliers, destinations, pricing, and trade routes

This video covers India's fenofibrate pharmaceutical import and export market — $73.4M in total trade, 168 verified manufacturers, and 81 destination countries. Data sourced from Indian Customs (DGFT) shipment records.

Regulatory Landscape — Fenofibrate

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

In the United States, fenofibrate is approved for the treatment of hypercholesterolemia and hypertriglyceridemia. The FDA has granted numerous Abbreviated New Drug Applications (ANDAs) for generic versions of fenofibrate, indicating a competitive market landscape. Notably, Teva Pharmaceutical Industries received final FDA approval for its generic fenofibrate tablets (54 mg and 160 mg) in May 2005. This approval followed a court ruling that Teva's product did not infringe upon existing patents.

The substantial number of approved ANDAs reflects a robust generic market, aligning with the presence of 168 active Indian exporters supplying fenofibrate to the U.S. This competitive environment underscores the importance of maintaining stringent quality standards and regulatory compliance to ensure market access.

2EU & UK Regulatory Framework

In the European Union, fenofibrate is authorized for use in combination with simvastatin under the brand name Cholib, with the European Commission granting marketing authorization on August 26, 2013. (ema.europa.eu) The European Medicines Agency (EMA) recommends fibrates, including fenofibrate, as second-line treatments, primarily for patients with severe hypertriglyceridemia or those intolerant to statins. (ema.europa.eu) Manufacturers exporting to the EU and UK must adhere to Good Manufacturing Practice (GMP) standards as outlined by the EMA and the UK's Medicines and Healthcare products Regulatory Agency (MHRA).

3WHO Essential Medicines & Global Standards

Fenofibrate is included in the National Essential Medicines Lists of several countries, such as Bhutan and Seychelles, indicating its recognized importance in managing lipid disorders. (cdn.who.int) While not listed on the WHO Model List of Essential Medicines, its inclusion in national lists underscores its therapeutic value. Compliance with international pharmacopoeia standards, including the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), and Indian Pharmacopoeia (IP), is essential for global market acceptance.

4India Regulatory Classification

In India, fenofibrate is classified under Schedule H of the Drugs and Cosmetics Act, requiring a prescription for dispensing. The Drug Price Control Order (DPCO), enforced by the National Pharmaceutical Pricing Authority (NPPA), regulates the pricing of essential medicines; however, specific ceiling prices for fenofibrate should be verified with the latest NPPA notifications. Exporters must obtain a No Objection Certificate (NOC) from the Directorate General of Foreign Trade (DGFT) for the export of pharmaceutical products, ensuring compliance with national regulations.

5Patent & Exclusivity Status

The primary patents for fenofibrate have expired, leading to a competitive generic market. For instance, Teva's generic fenofibrate received FDA approval in May 2005 following a court ruling of non-infringement. This expiration has facilitated the entry of multiple generic manufacturers, intensifying market competition.

6Recent Industry Developments

In December 2025, the EMA updated the product information for Cholib, a combination of fenofibrate and simvastatin, reflecting new safety data. (ema.europa.eu) This update underscores the importance of continuous pharmacovigilance and compliance with evolving regulatory requirements.

Additionally, in February 2026, the FDA approved a new generic formulation of fenofibrate, further increasing market competition and emphasizing the need for exporters to maintain high-quality standards to remain competitive.

These developments highlight the dynamic nature of the pharmaceutical industry and the necessity for exporters to stay informed about regulatory changes and market trends to ensure sustained success.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Supply Chain Risk Assessment — Fenofibrate

API sourcing, concentration risk, storage requirements, and current alerts

HIGH RISK

1API Sourcing & Raw Material Dependency

India's pharmaceutical industry, including the production of Fenofibrate, heavily relies on Active Pharmaceutical Ingredients (APIs) and Key Starting Materials (KSMs) imported from China. Approximately 60–70% of these critical components are sourced from Chinese manufacturers, making the supply chain vulnerable to disruptions stemming from geopolitical tensions, trade disputes, or regulatory changes.

In response to this dependency, the Indian government has initiated measures to bolster domestic production. In November 2024, under the Production Linked Incentive (PLI) scheme, two greenfield plants were inaugurated to manufacture essential molecules like Penicillin G, 6-APA, and Clavulanic Acid, aiming to reduce import reliance by half. However, these efforts are still in nascent stages and have yet to significantly impact the overall supply chain resilience for Fenofibrate.

2Supplier Concentration & Single-Source Risk

Our proprietary trade data indicates that the top five Indian exporters of Fenofibrate account for 53.3% of total exports, with ABBOTT HEALTHCARE PRIVATE LIMITED leading at a 14.5% share. This concentration poses a risk, as disruptions affecting these key suppliers could have a disproportionate impact on global supply.

The PLI scheme, launched in 2020, aims to incentivize domestic production of critical APIs and KSMs. While it has led to the establishment of new manufacturing units, the scheme's full impact on reducing supplier concentration and mitigating single-source risks remains to be seen.

Access Complete Fenofibrate Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 2,794 transactions across 81 markets.

Request Demo View Pricing

Frequently Asked Questions — Fenofibrate Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top fenofibrate exporters from India?

The leading fenofibrate exporters from India are ABBOTT HEALTHCARE PRIVATE LIMITED, HETERO LABS LIMITED, CIPLA LIMITED, and 12 others. ABBOTT HEALTHCARE PRIVATE LIMITED leads with 14.5% market share ($10.6M). The top 5 suppliers together control 53.3% of total export value.

What is the total export value of fenofibrate from India?

The total export value of fenofibrate from India is $73.4M, recorded across 2,794 shipments from 168 active exporters to 81 countries. The average shipment value is $26.3K.

Which countries import fenofibrate from India?

India exports fenofibrate to 81 countries. The top importing countries are UNITED STATES (43.4%), BELGIUM (8.7%), AUSTRALIA (8.2%), SOUTH KOREA (6.4%), FRANCE (6.4%), which together account for 73.0% of total export value.

What is the HS code for fenofibrate exports from India?

The primary HS code for fenofibrate exports from India is 30049099. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Fenofibrate

Fenofibrate

How India Exports Fenofibrate to the World

Top Fenofibrate Exporters from India

Top Countries Importing Fenofibrate from India

Who Supplies Fenofibrate to India?

Quick Facts

Related Lipid & Metabolism

Related Analysis

Need Details?

Fenofibrate — Export Intelligence Video

Regulatory Landscape — Fenofibrate

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Supply Chain Risk Assessment — Fenofibrate

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Fenofibrate Trade Intelligence

Frequently Asked Questions — Fenofibrate Exports from India

Who are the top fenofibrate exporters from India?

What is the total export value of fenofibrate from India?

Which countries import fenofibrate from India?

What is the HS code for fenofibrate exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of fenofibrate exports from India?

Which ports handle fenofibrate exports from India?

Why is India a leading exporter of fenofibrate?

What certifications do Indian fenofibrate exporters need?

How many buyers import fenofibrate from India?

What is the market share of the top fenofibrate exporter from India?

Analysis Methodology